CD7 and neoplasm: The dVHH NS7CAR-T cells demonstrated enhanced antigen-binding specificity, affinity, and anti-tumor efficacy in xenograft mouse models compared to single nanobody- and scFv-based CD7 CAR-T cells in xenograft models.